AzTrials
AzTrials

Survey ApplicationNCT06170502

Developing and Evaluating a Mobil Application AKILMOBIL

A study testing Using the mobile application and applying the survey in people with Survey Application, run by Eskisehir Osmangazi University at 1 site in Turkey (Türkiye).

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The research was planned to develop the mobile application (Akil Mobil) that will be designed for parents who continue to use drugs for their children at home after their child is discharged from the hospital and after the discharge education is completed. Read more about this study

Who is it for?
Any age, women onlyHealthy volunteers can take part
Conditions the study is for
Survey Application
What is being tested?
Using the mobile application and applying the survey
Could I receive a placebo?
No, everyone receives an active treatment
How many people
41 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Jan 2024to 1 Jan 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • Women only
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • Treating the disease condition and being discharged
  • Continuing to use medication at home after discharge
  • Parents should be able to speak and understand Turkish and be literate.
  • Having an Android mobile phone for the mobile application
  • Having the video call application on the mobile phone and accepting the video calling application to be made after 1 month
  • Voluntary written and verbal informed consent has been obtained from the parents.

Who cannot join

  • Parents' unwillingness to continue working at any stage of the research
  • Termination of drug use due to the termination of their children's treatment

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site, 1 recruiting
  • Aysegul

    Ankara, Mamak, 06100

    ayşegül karaca, 05337691532, aysegulkaraca_88@hotmail.com

    Recruiting

Other trials in Turkey (Türkiye)

About this study

Official title: Developing and Evaluating a Mobil Application for Rational Drug Use in Parents of Pediatric Patients After Discharge (Akilmobil)

The research was planned to develop the mobile application (Akil Mobil) that will be designed for parents who continue to use drugs for their children at home after their child is discharged from the hospital and after the discharge education is completed. The type of study is a randomized controlled experimental study.

Read the detailed description

The irrational use of drugs is a major problem all over the world. About half of the patients cannot use the drugs correctly. Over, under or misuse of drugs leads to waste of resources and poor health conditions. The patients and their relatives who manage the use of drugs at home are most important componenets in this regard. Administration of the medication at home to the children mostly lead by parents.

Despite being informed during discharge, parents can make many mistakes in adjusting the dosage, preparing and administering tablet, capsule, suspension forms of drugs. And there are difficulties in accessing reliable sources of information.

It is necessary to keep the knowledge and skills of the parents of children with chronic diseases, who uses drugs for a long time, up-to-date. Therefore, continuous and accessible training and support systems are needed. Recently, mobile applications that can be easily accessed from mobile phones have become widespread thanks to technological developments. Regardless of their socioeconomic level, anyone with a smartphone can use these applications. A mobile application with home drug preparation and application can provide information and support for parents in the preparation and administration of appropriate doses.

For this reason, the aim of this project is to develop and evaluate a mobile application (AkilMobil) that prevents parents who continue to use drugs for their children at home after their child is discharged from the hospital. The research is a randomized controlled experimental study. In the study, "Education Needs of Parents who Administering Medicines at Home Form", "Descriptive Information Form", "Parental Drug Preparation Information Evaluation Form", " Suspension Drug Administration Parent Evaluation Form", "Capsule Drug Administration Parent Evaluation Form", "Tablet Drug Administration Parent Evaluation Form", "Mobile Application Usability Questionnaire", "AkilMobil Expert Opinion Evaluation Form" developed by the researchers in line with the literature, and "STAI State Anxiety Inventory" developed by Spielberger et al. will be used.

In the application, there will be drug information, indications, effects, side effects, preparation and administration methods, instructions for use, drug interaction information, dose calculation and drug preparation videos of drugs that are frequently used in chronic diseases, which are understood by parents. Interaction with users will be provided with frequently asked questions and the opportunity to ask researchers directly. With this application, parents can prevent dose errors due to lack of information while preparing drugs at home and information pollution due to applying to incorrect and insufficient sources. The mobile application's ease of access, presentation of visual resources and providing understandable information are the original values of our work. It is a technological advance for rational drug use and quality health care.

Being tested
Using the mobile application and applying the survey
Keywords
drug, nurse, rational medicine

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Using the mobile application and applying the surveyDevice

    In the study, "The Form for Determining the Educational Needs of Parents Administering Medicines at Home", "Introductory Information Form", "Parental Drug Preparation Information Evaluation Form", "Parent Evaluation Form in Suspension Drug Administration", "Capsule Drug Application Parent Evaluation Form", developed by the researchers in line with the literature, "Tablet Pharmaceutical Application Parent Evaluation Form", "Mobile Application Usability Questionnaire", "AkilMobil Expert Opinion Evaluation Form" and "STAI State Anxiety Inventory" developed by Spielberger et al. will be used.

Study groups in NCT06170502
Study groupRoleWhat they receive
mobile application development and implementationExperimentalThe aim of the project is to develop and evaluate the effectiveness of a mobile application (AkilMobil) that prevents parents who continue to use drugs for their children at home after their child is discharged from the hospital. The research is a randomized controlled experimental study. In the study, "The Form for Determining the Educational Needs of Parents Administering Medicines at Home", "Introductory Information Form", "Parental Drug Preparation Information Evaluation Form", "Parent Evaluation Form in Suspension Drug Administration", "Capsule Drug Application Parent Evaluation Form", developed by the researchers in line with the literature, "Tablet Pharmaceutical Application Parent Evaluation Form", "Mobile Application Usability Questionnaire", "AkilMobil Expert Opinion Evaluation Form" and "STAI State Anxiety Inventory" developed by Spielberger et al. will be used.
Receives: Device: Using the mobile application and applying the survey

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Mobile Application Usability Survey

    Mothers with children with chronic diseases were evaluated with a mobile application usability survey, change in medication preparation activities in the 3rd month.

    Measured: 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Dec 2023
  2. Study start1 Jan 2024 (estimated)
  3. Primary completion1 Jan 2025 (estimated)
  4. Study completion1 Jan 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Model description
The type of study is a randomized controlled experimental study. In the research, it is aimed to evaluate the effectiveness of the mobile application (Akil Mobil).
Masking
None (open label)
Enrolment
41 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06170502
Sponsor's protocol ID
TUBITAK 2023
Status last verified
Dec 2023
First submitted
1 Sep 2023
Last updated
14 Dec 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: due to the development

Questions about this trial

What is this clinical trial studying?

A study testing Using the mobile application and applying the survey in people with Survey Application, run by Eskisehir Osmangazi University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 14 Dec 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Ayşegül Karaca (05337691532, aysegulkara_88@hotmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Mobile Application Usability Survey (time frame: 3 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Dec 2023.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in